It was found that the expression levels of WT1-AS were significantly lower (Fig. 1a, p < 0.05), while expression levels of TGF-β1 were substantially higher (Fig. 1b, p < 0.05) in NSCLC tissues compared to non-cancer tissues. The gene discussed is WT1; the disease is cancer.